TP53 and breast cancer: Our study shows that TP53 p.R337H mutation prevalence in breast cancer patients suspected of Hereditary Breast and Ovary Cancer Syndrome in Ribeirão Preto, São Paulo, Brazil is high (7.1%) and could play an important role in predisposition to breast cancer in this population.